Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02051101
Other study ID # 20139396
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 23, 2013
Est. completion date January 11, 2019

Study information

Verified date October 2022
Source University of California, Irvine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the pathogenic mechanisms of Port Wine Stain, collect biopsy samples and blood samples to characterize exosomes and metabolites from Port Wine Stain.


Description:

The researcher can detect the defects in nervous system innervation to cutaneous blood vessels contribute to the pathogenesis of Port Wine Stain . Unveiling the pathogenic mechanisms of PWS is crucial to the design of new therapeutic strategies and can use the results to improve current PWS therapeutic outcomes.


Recruitment information / eligibility

Status Completed
Enrollment 19
Est. completion date January 11, 2019
Est. primary completion date January 11, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 1 Day and older
Eligibility Inclusion Criteria: - Male or female of all ages. - Not pregnant. - Has diagnosis of port wine stain on the arms, legs, chest, bac. - Ability to understand and carry out subject instructions. - Subject willing to have skin biopsies on port wine stain and normal skin areas. Exclusion Criteria: - Pregnant women. - Port Wine Stain on the face. - History of skin cancer. - Current participation in an investigational drug evaluation - Concurrent use of known photosensitizing drugs.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Biopsy sample from Port Wine Stain Birthmark
Biopsy sample from Port Wine Stain Birthmark

Locations

Country Name City State
United States Beckman Laser Institute Irvine California

Sponsors (2)

Lead Sponsor Collaborator
University of California, Irvine Beckman Laser Institute University of California Irvine

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Characterization of Port Wine Stain Birthmark tissue sample up to 4 weeks
See also
  Status Clinical Trial Phase
Terminated NCT04336163 - Skin Imaging to Inform Laser Treatments N/A
Not yet recruiting NCT04536740 - Effect of Pulsed Dye Laser on Photodynamic Therapy of Port-Wine Stains N/A
Completed NCT00365118 - Treatment of Naevus Flammeus Using Intense Pulsed Light and Pulsed Dye Laser N/A
Completed NCT04106258 - A Pilot Study of Hemoporfin PDT in Children(2-7 Years Old) With Port-wine Stain Phase 4
Recruiting NCT05841628 - Tolerability of 532 nm Laser Treatment of Port Wine Stains N/A
Withdrawn NCT00667472 - Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks Phase 1
Completed NCT01924273 - Novel Treatment for Port Wine Stain Birthmarks Phase 1
Terminated NCT02214706 - Treatment of Port Wine Stains Using Pulsed Dye Laser, Erbium Yag Laser and Topical Sirolimus N/A
Completed NCT00540917 - Measurement Skin Temperature During Pulsed Laser Exposure Phase 2
Suspended NCT04103164 - Pilot Study to Evaluate the Effect of Multiple Passes on Port Wine Stain Treatments With the Cutera Excel V™ Laser. N/A
Completed NCT04999618 - A New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology Phase 4
Recruiting NCT05771311 - KTP Laser vs Pulsed Dye Laser for Port-Wine Stains N/A
Completed NCT01775722 - Combined Bipolar Radiofrequency&Pulsed Dye Laser Treatment N/A
Completed NCT01774552 - Evaluate the Port-wine Stain Birthmark Treatment Before and After Pulsed Dye Laser Treatment
Not yet recruiting NCT05171894 - A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin + PDT Phase 2
Completed NCT03181984 - Postmarketing Safety Study of Hemoporfin in Patients With Port Wine Stain Phase 4
Completed NCT03125057 - A Pilot Study of Hemoporfin PDT in Children With Port-wine Stain Phase 4